We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Emulate, a provider of next generation in vitro models, has secured $82m in Series E financing to support the development of new human-relevant organ-on-a-chip models. Led by existing
A research team at the RIKEN Center for Emergent Matter Science (CEMS) in Japan has developed a diagnostic system that can rapidly and sensitively measure the amount of
LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced it successfully utilized
Ophthalmic medical technology company Glaukos is seeking approval from the US Food and Drug Administration (FDA) for its iStent infinite trabecular micro-bypass system. The company has submitted a
Health technology company Hound Labs has secured $20m in capital to advance the production of its Hound marijuana breathalyser. The funds will be used by the company to
Medical data labelling company Centaur Labs has secured $15m in Series A financing round to boost its efforts to label the world’s medical data and accelerate artificial intelligence
Halma subsidiary SunTech Medical has completed the acquisition of medical devices and software solutions Hungary-based Meditech for an undisclosed sum. Based in Budapest, Meditech is engaged in the
U.S. Medical Glove Company LLC. (USMGC) purchased almost 700,000 pounds of Nitrile chemicals to begin stockpiling essential materials to produce medical gloves in the United States. US Medical
R3 Vascular Inc. today reported the successful initiation of its First-in-Human clinical study evaluating the technical and clinical performance of the R3 Vascular MAGNITUDE® Bioresorbable Sirolimus-Eluting Scaffold (BRS)
US-based healthcare company Baxter International has agreed to acquire medical technology company Hillrom for $10.5bn. The transaction values Hillrom at approximately $12.4bn, including the assumption of debt. Baxter